Mechnikov Institute of Biotechnology

The Mechnikov Institute of Biotechnology is a high-tech pharmaceutical facility located in Managua, Nicaragua, established as a joint venture between the St. Petersburg Institute of Vaccines and Sera (SPbIVS) of Russia and the Nicaraguan Social Security Institute (INSS). The company specializes in the production and distribution of immunobiological products, primarily focusing on influenza vaccines for the Latin American and Caribbean markets. It operates a state-of-the-art manufacturing plant designed to meet international Good Manufacturing Practice (GMP) standards, serving as a regional hub for vaccine supply and technology transfer. Beyond production, the institute aims to strengthen regional health security by providing affordable access to essential preventative medicines.